Skip to content

A prospective multicenter, open, single design, commercial trial to evaluate the safety and efficacy of NOVUS stent graft in patients with abdominal aortic aneurysm (AAA)

A prospective multicenter, open, single design, commercial trial to evaluate the safety and efficacy of NOVUS stent graft in patients with abdominal aortic aneurysm (AAA)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008585
Enrollment
98
Registered
2023-06-29
Start date
2024-01-12
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Common Selection Criteria - Adults between the ages of 19 and 90 who understand the purpose of the clinical trial, voluntarily consent, and sign a written consent form 2. Fusiform aneurysm - Abdominal aortic aneurysm more than 5.0 cm in diameter - If the diameter increases by more than 0.5cm in 6 months from 4-5cm in diameter or there are related clinical symptoms 3. Saccular aneurysm at risk of rupture 4. Pseudoaneurysm or aortic rupture 5. PAU (more than 2cm in width and more than 1cm in depth) - Selection criterion 1 must be satisfied, and only patients with one of the diseases of selection criteria 2, 3, 4, and 5 can be enrolled.

Exclusion criteria

Exclusion criteria: 1. Patients who do not want the procedure 2. Pregnant women 3. Diameter of the iliac artery < 5 mm when using a 15 Fr device, < 6 mm when using an 18 Fr device, and < 7 mm when using a 21 Fr device

Design outcomes

Primary

MeasureTime frame
Proportion of survivors without stent graft and cardiovascular complications

Secondary

MeasureTime frame
In case of target lesion re-operation or major camellia surgery; Cardiovascular complications (aorta, vascular-related death, myocardial infarction, major vascular damage, major stroke, paraplegia; In case of complication of stent graft in CT

Countries

Korea, Republic of

Contacts

Public ContactHOJONG CHUN

The Catholic University of Korea, Seoul St. Mary's Hospital

hojongchun@gmail.com+82-2-2258-1456

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 23, 2026